f

BUDGET WORKING 2021 - 2022 NAME OF ASM M.ASIM AZIZI AREA

2020-21 Calculated
ASM PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 1,448 100 1,548 142 1,704
Cebosh Tab. Value 467,704 32,300 500,004 45,866 550,392
Qzon IM inj. 0.25G 93.5 93.5 305 130 435 62 744
Qzon IV inj. 0.25G 93.5 93.5 100 70 170 20 240
Qzon IM inj. 0.5G 161.5 161.5 1,369 300 1,669 251 3,012
Qzon IV inj. 0.5G 161.5 161.5 95 30 125 6 72
Qzon IM inj. 1G 263.5 263.5 56 10 66 0 0
Qzon IV inj. 1G 263.5 263.5 1,073 310 1,383 230 2,760
Qzon Value 571,795 156,315 728,110 109,778 1,317,330
Somelinz Caps. 20mg 131.75 145.35 181 35 216 11 132
Somelinz Caps. 40mg 216.75 240.55 186 35 221 13 156
Somelinz Value 64,162 12,198 76,360 4,267 56,712
TOTAL VALUE 1,103,661 200,813 1,304,474 159,911 1,924,434

ATTIF JAMIL 2020-21 Calculated

SPO-1 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 1,448 100 1,548 142 1,704
Cebosh Tab. Value 467,704 32,300 500,004 45,866 550,392
Qzon IM inj. 0.25G 93.5 93.5 305 130 435 62 744
Qzon IV inj. 0.25G 93.5 93.5 100 70 170 20 240
Qzon IM inj. 0.5G 161.5 161.5 1,369 300 1,669 251 3,012
Qzon IV inj. 0.5G 161.5 161.5 95 30 125 6 72
Qzon IM inj. 1G 263.5 263.5 56 10 66 00
Qzon IV inj. 1G 263.5 263.5 1,073 310 1,383 230 2,760
Qzon Value 571,795 156,315 728,110 109,778 1,317,330
Somelinz Caps. 20mg 131.75 145.35 181 35 216 11 132
Somelinz Caps. 40mg 216.75 240.55 186 35 221 13 156
Somelinz Value 64,162 12,198 76,360 4,267 56,712
TOTAL VALUE 1,103,661 200,813 1,304,474 159,911 1,924,434
 f

2020-21 Calculated
SPO-2 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 0 0
Cebosh Tab. Value 0 0 0 0 0
Qzon IM inj. 0.25G 93.5 93.5 0 0
Qzon IV inj. 0.25G 93.5 93.5 0 0
Qzon IM inj. 0.5G 161.5 161.5 0 0
Qzon IV inj. 0.5G 161.5 161.5 0 0
Qzon IM inj. 1G 263.5 263.5 0 0
Qzon IV inj. 1G 263.5 263.5 0 0
Qzon Value 0 0 0 0 0
Somelinz Caps. 20mg 131.75 145.35 0 0
Somelinz Caps. 40mg 216.75 240.55 0 0
Somelinz Value 0 0 0 0 0
TOTAL VALUE 0 0 0 0 0

2020-21 Calculated
SPO-3 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 0 0
Cebosh Tab. Value 0 0 0 0 0
Qzon IM inj. 0.25G 93.5 93.5 0 0
Qzon IV inj. 0.25G 93.5 93.5 0 0
Qzon IM inj. 0.5G 161.5 161.5 0 0
Qzon IV inj. 0.5G 161.5 161.5 0 0
Qzon IM inj. 1G 263.5 263.5 0 0
Qzon IV inj. 1G 263.5 263.5 0 0
Qzon Value 0 0 0 0 0
Somelinz Caps. 20mg 131.75 145.35 0 0
Somelinz Caps. 40mg 216.75 240.55 0 0
Somelinz Value 0 0 0 0 0
TOTAL VALUE 0 0 0 0 0
 f

2020-21 Calculated
SPO-4 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 0 0
Cebosh Tab. Value 0 0 0 0 0
Qzon IM inj. 0.25G 93.5 93.5 0 0
Qzon IV inj. 0.25G 93.5 93.5 0 0
Qzon IM inj. 0.5G 161.5 161.5 0 0
Qzon IV inj. 0.5G 161.5 161.5 0 0
Qzon IM inj. 1G 263.5 263.5 0 0
Qzon IV inj. 1G 263.5 263.5 0 0
Qzon Value 0 0 0 0 0
Somelinz Caps. 20mg 131.75 145.35 0 0
Somelinz Caps. 40mg 216.75 240.55 0 0
Somelinz Value 0 0 0 0 0
TOTAL VALUE 0 0 0 0 0

2020-21 Calculated
SPO-5 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 0 0
Cebosh Tab. Value 0 0 0 0 0
Qzon IM inj. 0.25G 93.5 93.5 0 0
Qzon IV inj. 0.25G 93.5 93.5 0 0
Qzon IM inj. 0.5G 161.5 161.5 0 0
Qzon IV inj. 0.5G 161.5 161.5 0 0
Qzon IM inj. 1G 263.5 263.5 0 0
Qzon IV inj. 1G 263.5 263.5 0 0
Qzon Value 0 0 0 0 0
Somelinz Caps. 20mg 131.75 145.35 0 0
Somelinz Caps. 40mg 216.75 240.55 0 0
Somelinz Value 0 0 0 0 0
TOTAL VALUE 0 0 0 0 0
 f

2020-21 Calculated
SPO-6 PRODUCTS T.P (Rs.) T.P (Rs.) Unit Ach. YTD May Exp. June Units Total ACH Unit Sales Apr-21 Target 2021-22
Cebosh Tab. 400mg 323 323 0 0
Cebosh Tab. Value 0 0 0 0 0
Qzon IM inj. 0.25G 93.5 93.5 0 0
Qzon IV inj. 0.25G 93.5 93.5 0 0
Qzon IM inj. 0.5G 161.5 161.5 0 0
Qzon IV inj. 0.5G 161.5 161.5 0 0
Qzon IM inj. 1G 263.5 263.5 0 0
Qzon IV inj. 1G 263.5 263.5 0 0
Qzon Value 0 0 0 0 0
Somelinz Caps. 20mg 131.75 145.35 0 0
Somelinz Caps. 40mg 216.75 240.55 0 0
Somelinz Value 0 0 0 0 0
TOTAL VALUE 0 0 0 0 0
 f
SHEIKHUPURA

Adj. & Actual GOLY AVG /

Target 2021-22 Month
1,750 13.05% 146
565,250 13.05% 47,104
1,000 129.89% 83
800 370.59% 67
3,300 97.72% 275
800 540.00% 67
100 51.52% 8
3,000 116.92% 250
1,647,300 126.24% 137,275
600 177.78% 50
500 126.24% 42
207,485 171.72% 17,290
2,420,035 85.52% 201,670

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
1,750 13.05% 146
565,250 13.05% 47,104
1,000 129.89% 83
800 370.59% 67
3,300 97.72% 275
800 540.00% 67
100 51.52% 8
3,000 116.92% 250
1,647,300 126.24% 137,275
600 177.78% 50
500 126.24% 42
207,485 171.72% 17,290
2,420,035 85.52% 201,670
 f

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
0 #DIV/0! 0

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
0 #DIV/0! 0
 f

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
0 #DIV/0! 0

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
0 #DIV/0! 0
 f

Adj. & Actual AVG /

GOLY
Target 2021-22 Month
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
#DIV/0! 0
#DIV/0! 0
0 #DIV/0! 0
0 #DIV/0! 0
 f

Month Wise Target Bifurcaton

8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
151 147 148 445 148 149 151 447 151 130 151 431 130 148
48,612 47,481 47,764 143,856 47,764 48,046 48,612 144,421 48,612 41,829 48,612 139,052 41,829 47,764
86 84 85 255 85 85 86 256 86 74 86 246 74 85
69 67 68 204 68 68 69 204 69 59 69 197 59 68
284 277 279 840 279 281 284 843 284 244 284 812 244 279
69 67 68 204 68 68 69 204 69 59 69 197 59 68
9 8 8 25 8 9 9 26 9 7 9 25 7 8
258 252 254 764 254 255 258 767 258 222 258 738 222 254
141,668 138,373 139,197 419,238 139,197 140,021 141,668 420,885 141,668 121,900 141,668 405,236 121,900 139,197
52 50 51 153 51 51 52 153 52 44 52 148 44 51
43 42 42 127 42 43 43 128 43 37 43 123 37 42
17,844 17,429 17,532 52,805 17,532 17,636 17,844 53,012 17,844 15,354 17,844 51,041 15,354 17,532
208,123 203,283 204,493 615,899 204,493 205,703 208,123 618,319 208,123 179,083 208,123 595,329 179,083 204,493

Month Wise Target Bifurcaton

8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
151 147 148 445 148 149 151 447 151 130 151 431 130 148
48,612 47,481 47,764 143,856 47,764 48,046 48,612 144,421 48,612 41,829 48,612 139,052 41,829 47,764
86 84 85 255 85 85 86 256 86 74 86 246 74 85
69 67 68 204 68 68 69 204 69 59 69 197 59 68
284 277 279 840 279 281 284 843 284 244 284 812 244 279
69 67 68 204 68 68 69 204 69 59 69 197 59 68
9 8 8 25 8 9 9 26 9 7 9 25 7 8
258 252 254 764 254 255 258 767 258 222 258 738 222 254
141,668 138,373 139,197 419,238 139,197 140,021 141,668 420,885 141,668 121,900 141,668 405,236 121,900 139,197
52 50 51 153 51 51 52 153 52 44 52 148 44 51
43 42 42 127 42 43 43 128 43 37 43 123 37 42
17,844 17,429 17,532 52,805 17,532 17,636 17,844 53,012 17,844 15,354 17,844 51,041 15,354 17,532
208,123 203,283 204,493 615,899 204,493 205,703 208,123 618,319 208,123 179,083 208,123 595,329 179,083 204,493
 f
Month Wise Target Bifurcaton
8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0

Month Wise Target Bifurcaton

8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
 f
Month Wise Target Bifurcaton
8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0

Month Wise Target Bifurcaton

8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
 f
Month Wise Target Bifurcaton
8.60% 8.40% 8.45% 25.45% 8.45% 8.50% 8.60% 25.55% 8.60% 7.40% 8.60% 24.60% 7.40% 8.45%
Jul-21 Aug-21 Sep-21 QTR-1 Oct-21 Nov-21 Dec-21 QTR-2 Jan-22 Feb-22 Mar-22 QTR-3 Apr-22 May-22
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0
 f

8.55% 24.40%
Jun-22 QTR-4
150 427
48,329 137,921
86 244
68 195
282 805
68 195
9 24
257 732
140,844 401,941
51 146
43 122
17,740 50,626
206,913 590,489

8.55% 24.40%
Jun-22 QTR-4
150 427
48,329 137,921
86 244
68 195
282 805
68 195
9 24
257 732
140,844 401,941
51 146
43 122
17,740 50,626
206,913 590,489
 f

8.55% 24.40%
Jun-22 QTR-4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0

8.55% 24.40%
Jun-22 QTR-4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
 f

8.55% 24.40%
Jun-22 QTR-4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0

8.55% 24.40%
Jun-22 QTR-4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
 f

8.55% 24.40%
Jun-22 QTR-4
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0